Summary: Deutsche Boerse shares moved lower by about 1% on Friday after AlphaValue shifted its stance on the German exchange operator, downgrading the stock to "reduce" from "add". The broker said the recent share price rally has largely incorporated the company’s short- to medium-term growth prospects, limiting further upside from current levels.
AlphaValue points to a roughly 40% advance in Deutsche Boerse shares from their February lows as a key reason the stock now appears fairly valued. While the broker continues to describe the company as a high-quality business and a powerful earnings compounder, it concluded that much of the near-term growth is reflected in the current share price.
The broker reiterated several strengths of Deutsche Boerse in its assessment, noting diversified infrastructure, secular growth drivers and strong operating leverage as structural positives that support earnings generation. Nonetheless, AlphaValue expects the company’s EBITDA compound annual growth rate over 2024-2028 to come in slightly below the pace implied by management’s guidance.
Alongside the rating change, AlphaValue marginally increased its earnings per share estimates for 2026 and 2027. The broker also made clear that the planned acquisition of Allfunds (AMS:ALLFG) has not been incorporated into its financial model because the deal remains subject to regulatory approval.
Market reaction was visible in the share price, which retreated around 1% following the downgrade. The broker’s view effectively frames the recent rally as having priced in near-term growth, constraining potential upside absent new positive developments or the inclusion of the Allfunds transaction in published forecasts.
For investors and market participants, AlphaValue’s adjustment underscores the balance between recognizing a company's structural strengths and assessing valuation after a pronounced share-price recovery.
Market context limitations: The broker’s estimates and the current share price reflect assessments at the time of the downgrade; the Allfunds transaction remains excluded from AlphaValue’s published numbers pending regulatory clearance.